{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:04:43Z","timestamp":1790327083834,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA041180"],"award-info":[{"award-number":["R01-DA041180"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32-DA028874"],"award-info":[{"award-number":["T32-DA028874"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.neuropharm.2021.108480","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T11:42:35Z","timestamp":1612179755000},"page":"108480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms"],"prefix":"10.1016","volume":"186","author":[{"given":"Julia K.","family":"Brynildsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Blendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108480_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/jnci\/djq232","article-title":"Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study","volume":"102","author":"Amos","year":"2010","journal-title":"J. Natl. Canc. Inst."},{"key":"10.1016\/j.neuropharm.2021.108480_bib2","article-title":"Association of CHRNA5 gene variants with crack cocaine addiction","volume":"7","author":"Aroche","year":"2020","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.neuropharm.2021.108480_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.biopsych.2011.09.011","article-title":"Nicotinic \u03b15 subunits drive developmental changes in the activation and morphology of prefrontal cortex layer VI neurons","volume":"71","author":"Bailey","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108480_bib4","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.1523\/JNEUROSCI.2258-10.2010","article-title":"The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy","volume":"30","author":"Bailey","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.mp.4002154","article-title":"Alpha-5\/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking","volume":"13","author":"Berrettini","year":"2008","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108480_bib6","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41386-019-0462-0","article-title":"Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior","volume":"44","author":"Besson","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108480_bib7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1176\/appi.ajp.2008.07111711","article-title":"Variants in nicotinic receptors and risk for nicotine dependence","volume":"165","author":"Bierut","year":"2008","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108480_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psychres.2011.03.002","article-title":"Association of FKBP5, COMT and CHRNA5 polymorphisms with PTSD among outpatients at risk for PTSD","volume":"188","author":"Boscarino","year":"2011","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2021.108480_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1471-4159.2007.04700.x","article-title":"Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers","volume":"103","author":"Brown","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108480_bib10","series-title":"Presented at the Society for Neuroscience Annual Meeting, Washington, DC","article-title":"A common SNP in Chrna5 attenuates dopamine release from the nucleus accumbens in response to morphine","author":"Brynildsen","year":"2017"},{"key":"10.1016\/j.neuropharm.2021.108480_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1476-5381.1989.tb16873.x","article-title":"Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording","volume":"98","author":"Calabresi","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF02246095","article-title":"Habit-forming actions of nomifensine in nucleus accumbens","volume":"122","author":"Carlezon","year":"1995","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2021.108480_bib13","first-page":"672","article-title":"Low smoking exposure, the adolescent brain, and the modulating role of CHRNA5 polymorphisms","volume":"4","author":"Chaarani","year":"2019","journal-title":"Biol. Psychiatr. Cogn. Neurosci. Neuroimag."},{"key":"10.1016\/j.neuropharm.2021.108480_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jnci\/djv100","article-title":"CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis","volume":"107","author":"Chen","year":"2015","journal-title":"J. Natl. Canc. Inst."},{"key":"10.1016\/j.neuropharm.2021.108480_bib15","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1360-0443.2009.02697.x","article-title":"Interplay of genetic risk factors and parent monitoring in risk for nicotine dependence","volume":"104","author":"Chen","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2021.108480_bib16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ajmg.b.30919","article-title":"Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence","volume":"150B","author":"Chen","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/ntr\/ntr140","article-title":"Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada","volume":"13","author":"Conlon","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2021.108480_bib18","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1074\/jbc.270.9.4424","article-title":"Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions","volume":"270","author":"Conroy","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108480_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/ajad.12607","article-title":"Increased habenular connectivity in opioid users is associated with an \u03b15 subunit nicotinic receptor genetic variant","volume":"26","author":"Curtis","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2021.108480_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1460-9568.2010.07133.x","article-title":"Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes","volume":"31","author":"David","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuropharm.2018.06.031","article-title":"Knockout of alpha 5 nicotinic acetylcholine receptors subunit alters ethanol-mediated behavioral effects and reward in mice","volume":"138","author":"Dawson","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108480_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/bdrc.20118","article-title":"Nicotine and brain development","volume":"84","author":"Dwyer","year":"2008","journal-title":"Birth Defects Res. Part C Embryo Today - Rev."},{"key":"10.1016\/j.neuropharm.2021.108480_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2009.02.003","article-title":"The dynamic effects of nicotine on the developing brain","volume":"122","author":"Dwyer","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2021.108480_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00439-010-0876-6","article-title":"Nicotinic acetylcholine receptor genes on chromosome 15q25.1 are associated with nicotine and opioid dependence severity","volume":"128","author":"Erlich","year":"2010","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.addbeh.2009.05.010","article-title":"Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence","volume":"34","author":"Etter","year":"2009","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2021.108480_bib26","first-page":"162","article-title":"An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"29","author":"Falk","year":"2006","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.neuropharm.2021.108480_bib27","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1523\/JNEUROSCI.17-15-05747.1997","article-title":"Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine","volume":"17","author":"Fenster","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.pbb.2004.03.026","article-title":"Cue reactivity in smokers: the effects of perceived cigarette availability and gender","volume":"78","author":"Field","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2021.108480_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1471-4159.2000.0750018.x","article-title":"Neuronal and extraneuronal expression and regulation of the human alpha5 nicotinic receptor subunit gene","volume":"75","author":"Flora","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108480_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0026-895X(25)08832-7","article-title":"A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment","volume":"41","author":"Flores","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib31","article-title":"Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients","author":"Forget","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib32","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1016\/j.cub.2018.08.044","article-title":"A human polymorphism in CHRNA5 is linked to relapse to nicotine seeking in transgenic rats","volume":"28","author":"Forget","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature09797","article-title":"Habenular \u03b15 nicotinic receptor subunit signalling controls nicotine intake","volume":"471","author":"Fowler","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108480_bib34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuron.2011.04.013","article-title":"Aversion to nicotine is regulated by the balanced activity of \u03b24 and \u03b15 nicotinic receptor subunits in the medial habenula","volume":"70","author":"Frahm","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108480_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1601-183X.2009.00476.x","article-title":"Progesterone modulation of alpha5 nAChR subunits influences anxiety-related behavior during estrus cycle","volume":"8","author":"Gangitano","year":"2009","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2021.108480_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrg1635","article-title":"The genetics of addictions: uncovering the genes","volume":"6","author":"Goldman","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib37","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012120","article-title":"Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function","volume":"2","author":"Goriounova","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2021.108480_bib38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bcp.2009.06.011","article-title":"Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction","volume":"78","author":"Govind","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib39","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1523\/JNEUROSCI.5121-08.2009","article-title":"Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release","volume":"29","author":"Grady","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib40","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.biopsych.2008.04.018","article-title":"A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence","volume":"64","author":"Grucza","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108480_bib41","first-page":"109","article-title":"Scrutiny of the CHRNA5-CHRNA3-CHRNB4 smoking behavior locus reveals a novel association with alcohol use in a Finnish population based study","volume":"4","author":"H\u00e4llfors","year":"2013","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archgenpsychiatry.2009.2","article-title":"Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits","volume":"66","author":"Hong","year":"2009","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108480_bib43","doi-asserted-by":"crossref","first-page":"13509","DOI":"10.1073\/pnas.1004745107","article-title":"A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction","volume":"107","author":"Hong","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2021.108480_bib44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1601-183X.2011.00689.x","article-title":"A CHRNA5 allele related to nicotine addiction and schizophrenia","volume":"10","author":"Hong","year":"2011","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2021.108480_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00429-007-0150-4","article-title":"Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat","volume":"212","author":"Hoover","year":"2007","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2021.108480_bib46","doi-asserted-by":"crossref","first-page":"18022","DOI":"10.1523\/JNEUROSCI.2927-13.2013","article-title":"Medial habenula output circuit mediated by \u03b15 nicotinic receptor-expressing GABAergic neurons in the interpeduncular nucleus","volume":"33","author":"Hsu","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.20762","article-title":"Comparison of alpha2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice","volume":"493","author":"Ishii","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.110.165738","article-title":"Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice","volume":"334","author":"Jackson","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108480_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.107.132977","article-title":"Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs","volume":"325","author":"Jackson","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108480_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugalcdep.2011.06.009","article-title":"Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women","volume":"120","author":"Janes","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2021.108480_bib51","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1038\/npp.2015.131","article-title":"A CHRNA5 smoking risk variant decreases the aversive effects of nicotine in humans","volume":"40","author":"Jensen","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108480_bib52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3565(25)20732-7","article-title":"Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes","volume":"251","author":"Kalivas","year":"1989","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108480_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/nyas.12074","article-title":"Substance use disorders: a theory-driven approach to the integration of genetics and neuroimaging","volume":"1282","author":"Karoly","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1152\/physiolgenomics.00202.2003","article-title":"Mice lacking neuronal nicotinic acetylcholine receptor beta4-subunit and mice lacking both alpha5- and beta4-subunits are highly resistant to nicotine-induced seizures","volume":"17","author":"Kedmi","year":"2004","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.neuropharm.2021.108480_bib56","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.biopsych.2010.11.022","article-title":"Reduced interhemispheric resting state functional connectivity in cocaine addiction","volume":"69","author":"Kelly","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108480_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0033291798008022","article-title":"A population-based twin study in women of smoking initiation and nicotine dependence","volume":"29","author":"Kendler","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2021.108480_bib58","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.21-05-01452.2001","article-title":"Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei","volume":"21","author":"Klink","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm.4274","article-title":"Nicotine reverses hypofrontality in animal models of addiction and schizophrenia","volume":"23","author":"Koukouli","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108480_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/mol.110.066357","article-title":"Acetylcholine receptor (AChR) \u03b15 subunit variant associated with risk for nicotine dependence and lung cancer reduces (\u03b14\u03b22)\u2082\u03b15 AChR function","volume":"79","author":"Kuryatov","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/neu.10153","article-title":"The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences","volume":"53","author":"Le Nov\u00e8re","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib62","article-title":"Associations of variants in CHRNA5\/A3\/B4 gene cluster with smoking behaviors in a Korean population","volume":"5","author":"Li","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108480_bib63","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/mol.111.073841","article-title":"Functional characterization of the \u03b15(Asn398) variant associated with risk for nicotine dependence in the \u03b13\u03b24\u03b15 nicotinic receptor","volume":"80","author":"Li","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib64","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/S0024-3205(00)00789-X","article-title":"Distinct accumbal subareas are involved in place conditioning of amphetamine and cocaine","volume":"67","author":"Liao","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2009.05.038","article-title":"Dysfunctional connectivity patterns in chronic heroin users: an fMRI study","volume":"460","author":"Liu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108480_bib66","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.572","article-title":"Meta-analysis and imputation refines the association of 15q25 with smoking quantity","volume":"42","author":"Liu","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","article-title":"Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use","volume":"51","author":"Liu","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib68","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.neuroimage.2009.08.037","article-title":"Addiction related alteration in resting-state brain connectivity","volume":"49","author":"Ma","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2021.108480_bib69","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0896-6273(02)00625-6","article-title":"Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas","volume":"33","author":"Mansvelder","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108480_bib70","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/neu.10148","article-title":"Cellular and synaptic mechanisms of nicotine addiction","volume":"53","author":"Mansvelder","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib71","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.2007.05011.x","article-title":"The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo","volume":"104","author":"Mao","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108480_bib72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jnc.14989","article-title":"The nicotinic receptor alpha5 coding polymorphism rs16969968 as a major target in disease: functional dissection and remaining challenges","volume":"154","author":"Maskos","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108480_bib73","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108480_bib74","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/mp.2013.158","article-title":"Nicotine consumption is regulated by a human polymorphism in dopamine neurons","volume":"19","author":"Morel","year":"2014","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108480_bib75","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.0023-18.2018","article-title":"Chrna5-expressing neurons in the interpeduncular nucleus mediate aversion primed by prior stimulation or nicotine exposure","volume":"38","author":"Morton","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib76","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1111\/bph.12741","article-title":"The \u03b13\u03b24* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies","volume":"171","author":"Muldoon","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pbb.2013.04.015","article-title":"Morphine dependence and withdrawal induced changes in cholinergic signaling","volume":"109","author":"Neugebauer","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2021.108480_bib78","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1124\/jpet.103.056408","article-title":"Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography","volume":"307","author":"Nguyen","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108480_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12474","article-title":"The interaction of the Chrna5 D398N variant with developmental nicotine exposure","volume":"17","author":"O'Neill","year":"2018","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2021.108480_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/srep34341","article-title":"Increased nicotine response in iPSC-derived human neurons carrying the CHRNA5 N398 allele","volume":"6","author":"Oni","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108480_bib81","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ahg.12264","article-title":"CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population","volume":"82","author":"P\u00e9rez-Morales","year":"2018","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib82","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature12676","article-title":"Cortical interneurons that specialize in disinhibitory control","volume":"503","author":"Pi","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108480_bib83","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/37120","article-title":"Nicotine activates and desensitizes midbrain dopamine neurons","volume":"390","author":"Pidoplichko","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108480_bib84","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/cne.24221","article-title":"Specific connections of the interpeduncular subnuclei reveal distinct components of the habenulopeduncular pathway","volume":"525","author":"Quina","year":"2017","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib85","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nn1244","article-title":"Nicotine amplifies reward-related dopamine signals in striatum","volume":"7","author":"Rice","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001053","article-title":"Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD","volume":"6","author":"Saccone","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib87","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajmg.b.30828","article-title":"Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes","volume":"150B","author":"Saccone","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib88","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-09-0786","article-title":"The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans","volume":"69","author":"Saccone","year":"2009","journal-title":"Canc. Res."},{"key":"10.1016\/j.neuropharm.2021.108480_bib89","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/hmg\/ddl438","article-title":"Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs","volume":"16","author":"Saccone","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib90","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/mol.63.5.1059","article-title":"The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo","volume":"63","author":"Salas","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib91","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1523\/JNEUROSCI.4934-08.2009","article-title":"Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice","volume":"29","author":"Salas","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib92","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1124\/mol.65.6.1526","article-title":"Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice","volume":"65","author":"Salminen","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib93","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/acer.12009","article-title":"The \u03b15 neuronal nicotinic acetylcholine receptor subunit plays an important role in the sedative effects of ethanol but does not modulate consumption in mice","volume":"37","author":"Santos","year":"2013","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2021.108480_bib94","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.6828889","article-title":"Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo","volume":"220","author":"Schwartz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108480_bib95","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1096\/fj.14-268102","article-title":"Crucial role of nicotinic \u03b15 subunit variants for Ca2+ fluxes in ventral midbrain neurons","volume":"29","author":"Sciaccaluga","year":"2015","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2021.108480_bib96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.903200202","article-title":"Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area","volume":"320","author":"Sesack","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib97","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/npp.2010.64","article-title":"Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes","volume":"35","author":"Sherva","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108480_bib98","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/j.1360-0443.2008.02279.x","article-title":"Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with \u201cpleasurable buzz\u201d during early experimentation with smoking","volume":"103","author":"Sherva","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2021.108480_bib99","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1158\/1055-9965.EPI-08-0585","article-title":"Nicotinic receptor gene variants influence susceptibility to heavy smoking","volume":"17","author":"Stevens","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.neuropharm.2021.108480_bib100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3940(92)90518-C","article-title":"Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons","volume":"134","author":"Sugita","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108480_bib101","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.neuroimage.2012.01.117","article-title":"Resting state functional connectivity in addiction: lessons learned and a road ahead","volume":"62","author":"Sutherland","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2021.108480_bib102","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1046\/j.1471-4159.1995.65031407.x","article-title":"Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area","volume":"65","author":"Taber","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108480_bib103","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.neuropharm.2012.07.022","article-title":"Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by \u03b13\u03b24\u03b15 nicotinic acetylcholine receptors","volume":"63","author":"Tammim\u00e4ki","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108480_bib104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12881-018-0571-3","article-title":"Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women","volume":"19","author":"Tomaz","year":"2018","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026668","article-title":"\u201cSmoking genes\u201d: a genetic association study","volume":"6","author":"Verde","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108480_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2006.06.027","article-title":"Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat","volume":"142","author":"Vertes","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108480_bib107","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF02071877","article-title":"Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus laevis oocytes","volume":"15","author":"Vibat","year":"1995","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib108","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10519-004-1327-8","article-title":"Heritability of smoking initiation and nicotine dependence","volume":"35","author":"Vink","year":"2005","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(90)90248-A","article-title":"The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system","volume":"526","author":"Wada","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108480_bib110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/mp.2008.42","article-title":"Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence","volume":"14","author":"Wang","year":"2009","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108480_bib111","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1037\/0022-006X.72.6.1136","article-title":"Cue-provoked craving and nicotine replacement therapy in smoking cessation","volume":"72","author":"Waters","year":"2004","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2021.108480_bib112","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ajmg.b.31126","article-title":"Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance","volume":"153B","author":"Winterer","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2021.108480_bib113","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1038\/s41467-018-04654-2","article-title":"Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum","volume":"9","author":"Wolfman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108480_bib114","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neubiorev.2011.12.004","article-title":"Functional neuroimaging studies in addiction: multisensory drug stimuli and neural cue reactivity","volume":"36","author":"Yalachkov","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2021.108480_bib115","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nn769","article-title":"Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum","volume":"4","author":"Zhou","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108480_bib116","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:10:18Z","timestamp":1758438618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":116,"alternative-id":["S0028390821000344"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108480","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108480"}}